Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression
about
Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architectureAssociation of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control studyGene expression changes are age-dependent and lobe-specific in the brown Norway rat model of prostatic hyperplasiaOsteosarcoma cell-intrinsic colony stimulating factor-1 receptor functions to promote tumor cell metastasis through JAG1 signalingRole of CSF-1 in progression of epithelial ovarian cancerEffects of eicosapentaenoic acid and docosahexaenoic acid on prostate cancer cell migration and invasion induced by tumor-associated macrophages.CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.IL-1 induces IGF-dependent epithelial proliferation in prostate development and reactive hyperplasiaShould EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme.CSF-1 receptor-dependent colon development, homeostasis and inflammatory stress response.CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.Macrophage-dependent cleavage of the laminin receptor α6β1 in prostate cancer.Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resectionAutocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.Acute bacterial inflammation of the mouse prostate.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerIL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.Macrophage diversity in renal injury and repair.Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152CSF-1 signals directly to renal tubular epithelial cells to mediate repair in micemiR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1.Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatinDifferent phenotypes of monocytes in patients with new-onset mild acute pancreatitisFMS Kinase Inhibitors: Current Status and Future Prospects.IL-34 and CSF-1: similarities and differences.3D modeling and characterization of the human CD115 monoclonal antibody H27K15 epitope and design of a chimeric CD115 target.Cell-based biological evaluation of a new bisamide FMS kinase inhibitor possessing pyrrolo[3,2-c]pyridine scaffold.Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma.CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas.Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes.cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model.
P2860
Q24338443-8F115C27-7AE9-425F-84E7-AC78C8AE01C4Q24794971-F9E9C54B-61F4-4AC9-A8FE-53ADB4845D32Q28570394-274CB58B-E2B1-4865-9480-F8D9FDD40CBCQ33622657-AA150354-28DB-4965-996D-BD37DB7BA63DQ33694369-98A5011E-E9C1-4106-9F6E-48C6E62DA36BQ33748699-0A73D587-96E8-4640-87FA-9C880344EC1FQ33897765-5BF7B6DC-74CB-4F37-9953-DF7BF7AA37E7Q34077207-6A30E0FE-6A5E-4E9D-A3C6-441D7B3B24FEQ34077902-98105EB3-6DF1-4C81-9661-AC88FAE2B83AQ34115782-44F6AFF4-DEB9-4FCE-B6CF-2F10F5DB4324Q34171551-4D373A80-8A2D-4094-9AD8-BC33AC055E17Q34402141-4D3E3C6E-60C2-4B8F-B035-036218A41005Q34582493-F3BA5ED6-8D3F-47A5-8A8D-4820DAF0391CQ34602776-3D88F168-378C-46F3-B799-07605C4C4BA8Q35178381-97E586EF-37DC-4225-AA1E-76643BDA5F93Q35388139-0059EE34-C689-4CE2-8997-A113C085FFCDQ35582297-1E0F188A-B642-4D44-B56E-DBF271BAB41CQ35584172-0843E86E-E6D7-4B85-BAFB-B440E7CF1EA0Q35653176-B52D30D2-03E8-4FE3-80B3-9045E538A4BAQ35661399-93472EC4-CA4A-4B0C-BD9F-BCDBAEE170C2Q35985440-2789D2F0-E6FC-4D0A-BB75-C544D2B0CE33Q36161397-CAEE2D19-E146-497A-9F61-5E8B198A1A5BQ36462972-AC842793-ACFB-4BA4-9D73-3F84DC620B8BQ36955562-EB5BCC07-3B31-4223-B30F-1FBA38E2FC92Q36996594-EBE84716-C2A5-4967-A7DC-04D8B089A9C7Q37286616-C753DD08-9A9F-4A5D-A558-8CA07A1C6C49Q37362682-AD3771F5-E151-4AB4-9127-B87270298838Q37480291-ACC1E986-32A3-4195-8D6E-F5B6013DF46BQ37636636-3F92BCB0-4C29-4093-ABCD-A6C902C8B9B9Q37672248-FD578837-A0A4-4AF6-990B-E6FFAC4CA863Q37995562-C7A70DFD-DF30-43CA-B329-A6D546C09469Q38112353-DFAD940D-9BBC-4514-A001-3B8911A4F527Q38718166-A5DAF6E2-D30B-4B12-B5EE-F6F36F90FEF5Q38983252-3B478AFF-2B2D-405A-8147-38241B1CD4A9Q39005410-2465045A-3AE7-4C73-97D0-22F017BCC4CAQ39113879-55C637A7-4E2B-4D8E-9A44-4B0F6927DC51Q39567791-2F35968C-3844-4736-8872-FC07005C1903Q39986346-74B4329A-13C4-4C6D-AB97-B3D68C97BB28Q40089884-6ECA438B-5635-4E4F-87EC-FFE0D9031B3AQ40591603-E41C376E-14E5-451E-8076-DB659BFBD012
P2860
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression of colony-stimulati ...... nd prostate cancer progression
@ast
Expression of colony-stimulati ...... nd prostate cancer progression
@en
Expression of colony-stimulati ...... nd prostate cancer progression
@nl
type
label
Expression of colony-stimulati ...... nd prostate cancer progression
@ast
Expression of colony-stimulati ...... nd prostate cancer progression
@en
Expression of colony-stimulati ...... nd prostate cancer progression
@nl
prefLabel
Expression of colony-stimulati ...... nd prostate cancer progression
@ast
Expression of colony-stimulati ...... nd prostate cancer progression
@en
Expression of colony-stimulati ...... nd prostate cancer progression
@nl
P2093
P2860
P356
P1476
Expression of colony-stimulati ...... nd prostate cancer progression
@en
P2093
Barry M Kacinski
David B Seligson
Hisamitsu Ide
Maryann B Flick
Owen N Witte
Purnima Dubey
Sanaz Memarzadeh
Steve Horvath
P2860
P304
14404-14409
P356
10.1073/PNAS.222537099
P407
P577
2002-10-15T00:00:00Z